MTB vs PMCB · P/E 12, $30.99B cap vs $8.6M cap
M&T Bank Corporation (MTB) versus PharmaCyte Biotech Inc (PMCB) — a side-by-side from cached financials, not a winner call.
M&T Bank Corporation (MTB) is a banks - regional company listed on US.
PharmaCyte Biotech Inc (PMCB) is a biotechnology company listed on NASDAQ.
MTB does not have a complete income-statement cache yet.
Latest reported PMCB revenue for 2025-04-30 was $0. Net income was $30.7M. PMCB currently screens at market cap $8.6M.
MTB currently screens at market cap $30.99B and trailing P/E 11.9. PMCB currently screens at market cap $8.6M.
Not investment advice. Open the MTB and PMCB stock pages for the full models.
Not investment advice.